Analyticon Discovery GmbH
Records under this name other than the patents Analyticon Discovery GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 7 of 7 · Back to Analyticon Discovery GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,836,748 | Novel Bradykinin B2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,261,173 | Novel Bradykinin B2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,820,756 | Novel Bradykinin B2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 12,312,330 | 1-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,391,681 | (R)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)morpholine derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,653,172 | Natural stilbenes as sweeteners or sweetener enhancer Lapsed on the fee record Ended May 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 19, 2024 | From the USPTO record |
| US 7,078,418 | 1-aziridino-1-hydroxyiminomethyl-derivates, method for the production thereof and medicaments containing said compounds Formerly held Lapsed on the fee record Ended Jul 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2018 | From the USPTO record |